MedTrace Logo

BPAP in Pediatric Asthma Pilot Study

NCT04656587 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2023-02-14

No results posted yet for this study

Summary

The investigators aim to study the effect and safety of bilevel positive airway pressure (BPAP) in children with moderate to severe asthma exacerbations - by examining the effects of early initiation of BPAP in pediatric patients who present to the emergency room with a moderate to severe asthma exacerbation. The study is interested in how early initiation of BPAP affects PRAM scores, vital signs, as well as the total duration of continuous albuterol in the patient population.

Conditions

  • Asthma in Children
  • Status Asthmaticus

Interventions

DEVICE

Philips Respironics V60 Non-invasive ventilator, BPAP

Continuous albuterol will be administered through the BPAP circuit.

OTHER

Standard Therapy

Standard status asthmaticus therapy with continuous beta-agonist, steroids and oxygen as needed.

Sponsors & Collaborators

Principal Investigators

  • Patrick T Wilson, MD · Columbia University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-15
Primary Completion
2022-07-27
Completion
2022-07-27
FDA Device
Yes

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04656587 on ClinicalTrials.gov